Imunon Inc. Requests Hearing to Appeal Nasdaq Delisting as Stock Regains Compliance with Bid Price Requirement

Reuters

06-10

Imunon Inc. Requests Hearing to Appeal Nasdaq Delisting as Stock Regains Compliance with Bid Price Requirement

Imunon Inc. recently faced a potential delisting from Nasdaq due to non-compliance with the minimum bid price requirement and minimum stockholders' equity requirement. The company received a delisting determination letter on May 28, 2025, indicating that unless a hearing was requested, trading of its common stock would be suspended on June 6, 2025. Imunon Inc. requested a hearing on May 29, 2025, to appeal the delisting determination and seek a suspension of delisting pending its return to compliance. The hearing request has stayed the suspension of trading, allowing the company's stock to remain listed on Nasdaq until the Panel delivers a decision. In a positive development, warrant exercises provided Imunon Inc. with $2.0 million in proceeds, raising its stockholders' equity to $3.0 million as of May 31, 2025.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Imunon Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001641172-25-014279), on June 09, 2025, and is solely responsible for the information contained therein.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2542334475"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2542334475\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2542334475?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-06-10 02:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2542334475","market":"nz","top_or_hot":-1,"title":"Imunon Inc. Requests Hearing to Appeal Nasdaq Delisting as Stock Regains Compliance with Bid Price Requirement","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Imunon Inc. Requests Hearing to Appeal Nasdaq Delisting as Stock Regains Compliance with Bid Price Requirement\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Imunon Inc. recently faced a potential delisting from Nasdaq due to non-compliance with the minimum bid price requirement and minimum stockholders' equity requirement. The company received a delisting determination letter on May 28, 2025, indicating that unless a hearing was requested, trading of its common stock would be suspended on June 6, 2025. Imunon Inc. requested a hearing on May 29, 2025, to appeal the delisting determination and seek a suspension of delisting pending its return to compliance. The hearing request has stayed the suspension of trading, allowing the company's stock to remain listed on Nasdaq until the Panel delivers a decision. In a positive development, warrant exercises provided Imunon Inc. with $2.0 million in proceeds, raising its stockholders' equity to $3.0 million as of May 31, 2025.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Imunon Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001641172-25-014279), on June 09, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Imunon Inc. Requests Hearing to Appeal Nasdaq Delisting as Stock Regains Compliance with Bid Price Requirement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nImunon Inc. Requests Hearing to Appeal Nasdaq Delisting as Stock Regains Compliance with Bid Price Requirement\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-06-10 02:36</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Imunon Inc. Requests Hearing to Appeal Nasdaq Delisting as Stock Regains Compliance with Bid Price Requirement\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Imunon Inc. recently faced a potential delisting from Nasdaq due to non-compliance with the minimum bid price requirement and minimum stockholders' equity requirement. The company received a delisting determination letter on May 28, 2025, indicating that unless a hearing was requested, trading of its common stock would be suspended on June 6, 2025. Imunon Inc. requested a hearing on May 29, 2025, to appeal the delisting determination and seek a suspension of delisting pending its return to compliance. The hearing request has stayed the suspension of trading, allowing the company's stock to remain listed on Nasdaq until the Panel delivers a decision. In a positive development, warrant exercises provided Imunon Inc. with $2.0 million in proceeds, raising its stockholders' equity to $3.0 million as of May 31, 2025.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Imunon Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001641172-25-014279), on June 09, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250609:nNDLJZSkv:1","article_id":"2542334475","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2542334475","pubTimestamp":1749494161,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Imunon Inc. recently faced a potential delisting from Nasdaq due to non-compliance with the minimum bid price requirement and minimum stockholders' equity requirement. The company received a delisting determination letter on May 28, 2025, indicating that unless a hearing was requested, trading of its common stock would be suspended on June 6, 2025. Imunon Inc. requested a hearing on May 29, 2025, to appeal the delisting determination and seek a suspension of delisting pending its return to compliance. The hearing request has stayed the suspension of trading, allowing the company's stock to remain listed on Nasdaq until the Panel delivers a decision. In a positive development, warrant exercises provided Imunon Inc. with $2.0 million in proceeds, raising its stockholders' equity to $3.0 million as of May 31, 2025.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","IMNN":"Imunon, Inc."},"translate_title":"Imunon Inc.要求举行听证会，对纳斯达克退市提出上诉，因为股票重新符合买入价要求","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IMNN":0.9},"content_text":"Imunon Inc. Requests Hearing to Appeal Nasdaq Delisting as Stock Regains Compliance with Bid Price Requirement\n    \n\n        Imunon Inc. recently faced a potential delisting from Nasdaq due to non-compliance with the minimum bid price requirement and minimum stockholders' equity requirement. The company received a delisting determination letter on May 28, 2025, indicating that unless a hearing was requested, trading of its common stock would be suspended on June 6, 2025. Imunon Inc. requested a hearing on May 29, 2025, to appeal the delisting determination and seek a suspension of delisting pending its return to compliance. The hearing request has stayed the suspension of trading, allowing the company's stock to remain listed on Nasdaq until the Panel delivers a decision. In a positive development, warrant exercises provided Imunon Inc. with $2.0 million in proceeds, raising its stockholders' equity to $3.0 million as of May 31, 2025.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Imunon Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001641172-25-014279), on June 09, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}